Company intelligence / Profile preview

I.Ceram

Ownership: Private
Development stage: Other

Overview

I.Ceram has developed and commercialized a range of high-tech ceramic and composite implants for orthopedic and reconstructive surgery. In 2024, the company launched a pilot clinical study in Paris to evaluate its innovative antibiotic-loaded Porous Ceramic Sternal Stabilisation Implant designed to improve chest wall stability and prevent infections after cardiac surgery. The implant aims to reduce complications such as post-operative mediastinitis. Other products are already marketed.

Therapeutic areas: Infectious DiseasesRheumatologyCardiovascular
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Partnerships

Collaboration with Professor Pascal Leprince for pilot clinical study on sternal implant

Beyond the preview

Go deeper on I.Ceram.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on I.Ceram.

Explore the full profile